Results 171 to 180 of about 96,603 (330)

Presentation, diagnosis and treatment of a prostatic abscess in an adult, male, neutered cat

Veterinary Record Case Reports, Volume 14, Issue 1, February 2026.
Abstract A 6‐year‐old, male, neutered Maine Coon cat presented with a 1‐week history of hyporexia, stranguria, pollakiuria and dysuria. Investigations, including abdominal ultrasound, positive contrast retrograde urethrocystogram and cytology of the prostate, were most consistent with a prostatic abscess.
Lydia Bloomfield, Natasha May, Andrea Holmes, Anna Frykfors von Hekkel   +3 more
wiley   +1 more source

Productivity losses and treatment cost of benign prostatic hyperplasia in Ghana. [PDF]

PLoS One
Dadee-Seshie DS, Agbeteti SG, Kpankyaano B, Adamu AF, Adanu SK, Alhassan Y, Dalaba MA, Adanu KK.   +7 more
europepmc   +1 more source

A controlled clinical trial to evaluate the efficacy of Tilanala Kshara in the management of Vatashteela vis-a-vis Benign Prostatic Hyperplasia

, 2022
Rahul Ravi P, V. Rajendra
openalex   +2 more sources

The aporetic dialogs of Modena on gender differences: Is it all about testosterone? Episode III: Mathematics

Andrology, Volume 14, Issue 2, Page 335-344, February 2026.
Abstract This report is the transcript of what was discussed in a convention at the Endocrinology Unit in Modena, Italy, in the form of the aporetic dialogs of ancient Greece. It is the third episode of a series of four discussions on the differences between males and females, with a multidisciplinary approach. In this work, the role of testosterone in
Giulia Brigante, Francesco Costantino, Alessio Bellelli, Stefano Boni, Chiara Furini, Rita Cucchiara, Manuela Simoni   +6 more
wiley   +1 more source

Airborne chloride exposure and benign prostatic hyperplasia risk. [PDF]

BMC Res Notes
Shi J, Phanumartwiwath A.
europepmc   +1 more source

The Use of 5-Alpha Reductase Inhibitors to Manage Benign Prostatic Hyperplasia and the Risk of All-cause Mortality

, 2018
Lauren P. Wallner, Julia DiBello, Bonnie H. Li, Stephen K. Van Den Eeden, Sheila Weinmann, Debra P. Ritzwoller, Jill E. Abell, Ralph B. D’Agostino, Ronald K. Loo, David S. Aaronson, Ralph I. Horwitz, Steven J. Jacobsen   +11 more
openalex   +2 more sources

Patient‐reported outcome measures in prostate research: a scoping review

BJU International, Volume 137, Issue 2, Page 241-250, February 2026.
Objectives To summarise how patient‐reported outcome measures (PROMs) are used in prostate research, specifically in the 10 years after the 2010 CONsolidated Standards Of Reporting Trials (CONSORT) guidelines were introduced. Methods The search was focussed on randomised controlled trials (RCTs) reporting in the top 15 journals in oncology, urology ...
Grace J. Young, Eleanor I. Walsh, J. Athene Lane, Jenny L. Donovan, Marcus J. Drake, Hugo Pedder, Chris Metcalfe   +6 more
wiley   +1 more source

Integrated management strategies for benign prostatic hyperplasia. [PDF]

Front Urol
Zhou Y, Luo Q, Wang R, Zheng D, Xiong Y, Zuo J, Wang S, Zhong L.   +7 more
europepmc   +1 more source

Benign prostatic hyperplasia

BMJ, 1999
openaire   +3 more sources

Prostate zonal impact of 5α‐reductase inhibitors on multiparametric MRI characteristics and detection of prostate cancer

BJU International, Volume 137, Issue 2, Page 332-338, February 2026.
Objectives To assess the impact of 5α‐reductase inhibitors (5‐ARIs) on multiparametric magnetic resonance imaging (mpMRI) features of Prostate Imaging‐Reporting and Data System (PI‐RADS) lesions and their influence on the detection of clinically significant prostate cancer (csPCa), with a focus on differences between prostate zones.
Arighno Das, Marcelo Bigarella, Krista Brackman, Glenn O. Allen, Soroush Rais‐Bahrami, Kayla Bahr, Emily Schmitt, Andrew M. Fang, Hunter Boudreau, Christopher P. Filson, Melina Pectasides, Giuseppe V. Toia, David F. Jarrard   +12 more
wiley   +1 more source